Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Jorgensen

Showing results (511-520 of 567) with videos related to

Pageof 57
Sort By:
JMIR Research Protocols|July 19, 2023
A "Bundle of Care" to Improve Anticoagulation Control in Patients Receiving Warfarin in Uganda and South Africa: Protocol for an Implementation StudyAndrea L Jorgensen, Catherine Orrell, Catriona Waitt, et al.
Cell Death & Disease|December 6, 2019
Exploring the potential of BH3 mimetic therapy in squamous cell carcinoma of the head and neckRachel J Carter, Mateus Milani, Michael Butterworth, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 10, 2021
Stable warfarin dose prediction in sub-Saharan African patients: A machine-learning approach and external validation of a clinical dose-initiation algorithmInnocent G Asiimwe, Marc Blockman, Karen Cohen, et al.
ACS Central Science|March 31, 2021
Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2 from Molecular Sculpting of the Drug Perampanel Guided by Free Energy Perturbation CalculationsChun-Hui Zhang, Elizabeth A Stone, Maya Deshmukh, et al.
Chemical Science|November 8, 2014
Illuminating HIV gp120-Ligand Recognition through Computationally-Driven Optimization of Antibody-Recruiting MoleculesChristopher G Parker, Markus K Dahlgren, Ran N Tao, et al.
Molecular Cancer Therapeutics|July 16, 2014
Biochemical assays for the discovery of TDP1 inhibitorsChristophe Marchand, Shar-yin N Huang, Thomas S Dexheimer, et al.
Blood|July 10, 2013
Detection of MRD may predict the outcome of patients with Philadelphia chromosome-positive ALL treated with tyrosine kinase inhibitors plus chemotherapyFarhad Ravandi, Jeffrey L Jorgensen, Deborah A Thomas, et al.
Frontiers in Pharmacology|October 10, 2022
A genome-wide association study of plasma concentrations of warfarin enantiomers and metabolites in sub-Saharan black-African patientsInnocent G Asiimwe, Marc Blockman, Karen Cohen, et al.
Blood Advances|December 22, 2020
Prognostic impact of complete remission with MRD negativity in patients with relapsed or refractory AMLNicholas J Short, Hind Rafei, Naval Daver, et al.
ACS Medicinal Chemistry Letters|August 19, 2021
Optimization of Triarylpyridinone Inhibitors of the Main Protease of SARS-CoV-2 to Low-Nanomolar Antiviral PotencyChun-Hui Zhang, Krasimir A Spasov, Raquel A Reilly, et al.
Pageof 57

Showing results (511-520 of 567) with videos related to

Sort By:
Pageof 57
JMIR Research Protocols|July 19, 2023
A "Bundle of Care" to Improve Anticoagulation Control in Patients Receiving Warfarin in Uganda and South Africa: Protocol for an Implementation StudyAndrea L Jorgensen, Catherine Orrell, Catriona Waitt, et al.
Cell Death & Disease|December 6, 2019
Exploring the potential of BH3 mimetic therapy in squamous cell carcinoma of the head and neckRachel J Carter, Mateus Milani, Michael Butterworth, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 10, 2021
Stable warfarin dose prediction in sub-Saharan African patients: A machine-learning approach and external validation of a clinical dose-initiation algorithmInnocent G Asiimwe, Marc Blockman, Karen Cohen, et al.
ACS Central Science|March 31, 2021
Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2 from Molecular Sculpting of the Drug Perampanel Guided by Free Energy Perturbation CalculationsChun-Hui Zhang, Elizabeth A Stone, Maya Deshmukh, et al.
Chemical Science|November 8, 2014
Illuminating HIV gp120-Ligand Recognition through Computationally-Driven Optimization of Antibody-Recruiting MoleculesChristopher G Parker, Markus K Dahlgren, Ran N Tao, et al.
Molecular Cancer Therapeutics|July 16, 2014
Biochemical assays for the discovery of TDP1 inhibitorsChristophe Marchand, Shar-yin N Huang, Thomas S Dexheimer, et al.
Blood|July 10, 2013
Detection of MRD may predict the outcome of patients with Philadelphia chromosome-positive ALL treated with tyrosine kinase inhibitors plus chemotherapyFarhad Ravandi, Jeffrey L Jorgensen, Deborah A Thomas, et al.
Frontiers in Pharmacology|October 10, 2022
A genome-wide association study of plasma concentrations of warfarin enantiomers and metabolites in sub-Saharan black-African patientsInnocent G Asiimwe, Marc Blockman, Karen Cohen, et al.
Blood Advances|December 22, 2020
Prognostic impact of complete remission with MRD negativity in patients with relapsed or refractory AMLNicholas J Short, Hind Rafei, Naval Daver, et al.
ACS Medicinal Chemistry Letters|August 19, 2021
Optimization of Triarylpyridinone Inhibitors of the Main Protease of SARS-CoV-2 to Low-Nanomolar Antiviral PotencyChun-Hui Zhang, Krasimir A Spasov, Raquel A Reilly, et al.
Pageof 57